Hemostasis Today

March, 2026
March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Kymentie Ferdinande: Rivaroxaban in Cirrhosis and the Path Toward Individualized Anticoagulation
Mar 11, 2026, 15:34

Kymentie Ferdinande: Rivaroxaban in Cirrhosis and the Path Toward Individualized Anticoagulation

Kymentie Ferdinande, PhD Researcher UNIPD at University of Padova, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:

“We are pleased to share our Letter to the Editor in Journal of Thrombosis and Haemostasis (JTH) commenting on the recent work by Cindy Pereira Portela, Lorenzo Alberio and colleagues on the effect of direct oral anticoagulants in cirrhosis.

In this letter, we present complementary in vitro data on rivaroxaban in cirrhosis, in line with those of Portela et al.. Together, these observations support the need for more individualized anticoagulation strategies in cirrhosis, an area that warrants further investigation.

Many thanks to the authors for their interesting reply!”

Title: “Effect of direct oral anticoagulants in cirrhosis: an in vitro study”: comment

Authors: Kymentie Ferdinande, Jill Vercruyssen, Jochen Decaestecker, Charlotte De Vloo, Inge Van Haute, Helena Degroote, Sarah Raevens, Xavier Verhelst, Anja Geerts, Hans Van Vlierberghe, Katrien M. J. Devreese

Read the Full Article on Journal of Thrombosis and Hemostasis

Kymentie Ferdinande

Stay updated on all scientific advances with Hemostasis Today.